ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39294-1mg |
|
1212704-51-2 |
Jarin-1
|
0 | C28H29N3O4 | |
GC39293-100mg |
|
325457-89-4 |
ICA-27243
|
0 | C12H7ClF2N2O | |
GC39293-50mg |
|
325457-89-4 |
ICA-27243
|
0 | C12H7ClF2N2O | |
GC39293-10mg |
|
325457-89-4 |
ICA-27243
|
0 | C12H7ClF2N2O | |
GC39293-5mg |
|
325457-89-4 |
ICA-27243
|
0 | C12H7ClF2N2O | |
GC39293-10mM (in 1mL DMSO) |
|
325457-89-4 |
ICA-27243
|
0 | C12H7ClF2N2O | |
GC39292-5mg |
|
2216763-38-9 |
Rheb inhibitor NR1
|
0 | C25H19BrCl2N2O3S | |
GC39291-100mg |
|
2136270-20-5 |
SPOP-IN-6b
|
0 | C28H32N6O3 | |
GC39291-50mg |
|
2136270-20-5 |
SPOP-IN-6b
|
0 | C28H32N6O3 | |
GC39291-10mg |
|
2136270-20-5 |
SPOP-IN-6b
|
0 | C28H32N6O3 | |
GC39291-5mg |
|
2136270-20-5 |
SPOP-IN-6b
|
0 | C28H32N6O3 | |
GC39291-10mM (in 1mL DMSO) |
|
2136270-20-5 |
SPOP-IN-6b
|
0 | C28H32N6O3 | |
GC39290-100mg |
|
96702-03-3 |
Ectoine
|
0 | C6H10N2O2 | |
GC39290-10 mM ( 1 mL in Water) |
|
96702-03-3 |
Ectoine
|
0 | C6H10N2O2 | |
GC39289-5mg |
|
2064175-32-0 |
FKBP12 PROTAC dTAG-7
|
0 | C63H79N5O19 | |
GC39288-10mg |
|
629652-72-8 |
ent-Tadalafil
|
0 | C22H19N3O4 | |
GC39288-5mg |
|
629652-72-8 |
ent-Tadalafil
|
0 | C22H19N3O4 | |
GC39287-100mg |
|
2097523-60-7 |
LSD1-IN-7 benzenesulfonate
|
0 | C30H29F2N5O5S | |
GC39287-50mg |
|
2097523-60-7 |
LSD1-IN-7 benzenesulfonate
|
0 | C30H29F2N5O5S | |
GC39287-10mg |
|
2097523-60-7 |
LSD1-IN-7 benzenesulfonate
|
0 | C30H29F2N5O5S | |